Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

doxorubicin/perfluorooctyl bromide-loaded poly(lactic-co-glycolic acid)-poly(ethylene glycol)-folic acid

Based on

1 Articles
2016 Most recent source

Composition

1

poly(lactic-co-glycolic acid)-poly(ethylene glycol)/poly(lactic-co-glycolic acid)-poly(ethylene glycol)-folic acid

PLGA-PEG/PLGA-PEG-folate
Type Complex Compound
Formula
Role carriers
2

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material
3

1-bromoheptadecafluorooctane

perfluorooctyl bromide perfluorooctylbromide perfluoroctylbromide PFOB
Type Single Compound
Formula C8BrF17
Role loaded material

Properties

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Source
human cervical cancer HeLa cells

1 more entry available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 1-bromoheptadecafluorooctane
  • poly(lactic-co-glycolic acid)-poly(ethylene glycol)-folic acid
  • adriblastin
See all (4)
  1. XijR9yJfM8IRRZFTv9KwrGfk
Product

doxorubicin/perfluorooctyl bromide-loaded poly(lactic-co-glycolic acid)-poly(ethylene glycol)-folic acid

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial